☰

Maddalena Mereu, PhD - Publications

Affiliations: 
Intramural Research Program National Institute on Drug Abuse 
Area:
Molecular Targets and Medication Discovery Branch
Tree Info Grants Similar researchers PubMed Report error

34 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Managò F, Scheggia D, Pontillo M, Mereu M, Mastrogiacomo R, Udayan G, Valentini P, Tata MC, Weinberger DR, Weickert CS, Pompa PP, De Luca MA, Vicari S, Papaleo F. Dopaminergic signaling and behavioral alterations by Comt-Dtnbp1 genetic interaction and their clinical relevance. British Journal of Pharmacology. PMID 37218669 DOI: 10.1111/bph.16147  0.762
2022 Gregorio I, Mereu M, Contarini G, Bello L, Semplicini C, Burgio F, Russo L, Sut S, Dall'Acqua S, Braghetta P, Semenza C, Pegoraro E, Papaleo F, Bonaldo P, Cescon M. Collagen VI deficiency causes behavioral abnormalities and cortical dopaminergic dysfunction. Disease Models & Mechanisms. PMID 35946603 DOI: 10.1242/dmm.049481  0.627
2021 Cerantola S, Caputi V, Contarini G, Mereu M, Bertazzo A, Bosi A, Banfi D, Mantini D, Giaroni C, Giron MC. Dopamine Transporter Genetic Reduction Induces Morpho-Functional Changes in the Enteric Nervous System. Biomedicines. 9. PMID 33923250 DOI: 10.3390/biomedicines9050465  0.335
2020 Mereu M, Hiranita T, Jordan CJ, Chun LE, Lopez JP, Coggiano MA, Quarterman JC, Bi GH, Keighron JD, Xi ZX, Newman AH, Katz JL, Tanda G. Modafinil potentiates cocaine self-administration by a dopamine-independent mechanism: possible involvement of gap junctions. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32340023 DOI: 10.1038/S41386-020-0680-5  0.342
2019 Espinoza S, Scarpato M, Damiani D, Managò F, Mereu M, Contestabile A, Peruzzo O, Carninci P, Santoro C, Papaleo F, Mingozzi F, Ronzitti G, Zucchelli S, Gustincich S. SINEUP Non-coding RNA Targeting GDNF Rescues Motor Deficits and Neurodegeneration in a Mouse Model of Parkinson's Disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 31495777 DOI: 10.1016/J.Ymthe.2019.08.005  0.617
2019 Leggio GM, Torrisi SA, Mastrogiacomo R, Mauro D, Chisari M, Devroye C, Scheggia D, Nigro M, Geraci F, Pintori N, Giurdanella G, Costa L, Bucolo C, Ferretti V, Sortino MA, ... ... Mereu M, et al. The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans. Molecular Psychiatry. PMID 31492942 DOI: 10.1038/S41380-019-0511-4  0.739
2019 Castellani G, Contarini G, Mereu M, Albanesi E, Devroye C, D'Amore C, Ferretti V, De Martin S, Papaleo F. Dopamine-Mediated Immunomodulation affects Choroid Plexus Function. Brain, Behavior, and Immunity. PMID 31175999 DOI: 10.1016/J.Bbi.2019.06.006  0.764
2018 Scheggia D, Mastrogiacomo R, Mereu M, Sannino S, Straub RE, Armando M, Managò F, Guadagna S, Piras F, Zhang F, Kleinman JE, Hyde TM, Kaalund SS, Pontillo M, Orso G, et al. Publisher Correction: Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment. Nature Communications. 9: 3560. PMID 30158661 DOI: 10.1038/S41467-018-06062-Y  0.726
2018 Scheggia D, Mastrogiacomo R, Mereu M, Sannino S, Straub RE, Armando M, Managò F, Guadagna S, Piras F, Zhang F, Kleinman JE, Hyde TM, Kaalund SS, Pontillo M, Orso G, et al. Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment. Nature Communications. 9: 2265. PMID 29891954 DOI: 10.1038/S41467-018-04711-W  0.78
2017 Ciampoli M, Contarini G, Mereu M, Papaleo F. Attentional Control in Adolescent Mice Assessed with a Modified Five Choice Serial Reaction Time Task. Scientific Reports. 7: 9936. PMID 28855580 DOI: 10.1038/S41598-017-10112-8  0.626
2017 Scheggia D, Zamberletti E, Realini N, Mereu M, Contarini G, Ferretti V, Managò F, Margiani G, Brunoro R, Rubino T, De Luca MA, Piomelli D, Parolaro D, Papaleo F. Remote memories are enhanced by COMT activity through dysregulation of the endocannabinoid system in the prefrontal cortex. Molecular Psychiatry. PMID 28630452 DOI: 10.1038/Mp.2017.126  0.758
2017 Sannino S, Padula MC, Managò F, Schaer M, Schneider M, Armando M, Scariati E, Sloan-Bena F, Mereu M, Pontillo M, Vicari S, Contarini G, Chiabrera C, Pagani M, Gozzi A, et al. Adolescence is the starting point of sex-dichotomous COMT genetic effects. Translational Psychiatry. 7: e1141. PMID 28556830 DOI: 10.1038/Tp.2017.109  0.646
2017 Mereu M, Contarini G, Buonaguro EF, Latte G, Managò F, Iasevoli F, de Bartolomeis A, Papaleo F. Dopamine transporter (DAT) genetic hypofunction in mice produces alterations consistent with ADHD but not schizophrenia or bipolar disorder. Neuropharmacology. 121: 179-194. PMID 28454982 DOI: 10.1016/J.Neuropharm.2017.04.037  0.694
2017 Huang H, Guadagna S, Mereu M, Ciampoli M, Pruzzo G, Ballard T, Papaleo F. A schizophrenia relevant 5-Choice Serial Reaction Time Task for mice assessing broad monitoring, distractibility and impulsivity. Psychopharmacology. PMID 28378204 DOI: 10.1007/S00213-017-4611-Z  0.743
2017 Caputi, Marsilio I, Cerantola S, Mereu M, Contarini G, Paquola A, Orso G, Giaroni C, Papaleo F, Giron M. Dopamine transporter genetic reduction affects small- bowel neuromuscular contractility in mice Neurogastroenterology and Motility. 29: 17-17. DOI: 10.1111/Nmo.13180/Epdf  0.657
2016 Talbot JN, Geffert LM, Jorvig JE, Goldstein RI, Nielsen CL, Wolters NE, Amos ME, Munro CA, Dallman E, Mereu M, Tanda G, Katz JL, Indarte M, Madura JD, Choi H, et al. Rapid and sustained antidepressant properties of an NMDA antagonist/monoamine reuptake inhibitor identified via transporter-based virtual screening. Pharmacology, Biochemistry, and Behavior. PMID 27569602 DOI: 10.1016/J.Pbb.2016.08.007  0.386
2016 Mereu M, Chun LE, Prisinzano T, Newman AH, Katz JL, Tanda G. The Unique Psychostimulant Profile of (±)-Modafinil: Investigation of Behavioral and Neurochemical Effects in Mice. The European Journal of Neuroscience. PMID 27545285 DOI: 10.1111/Ejn.13376  0.395
2016 Managò F, Mereu M, Mastwal S, Mastrogiacomo R, Scheggia D, Emanuele M, De Luca MA, Weinberger DR, Wang KH, Papaleo F. Genetic Disruption of Arc/Arg3.1 in Mice Causes Alterations in Dopamine and Neurobehavioral Phenotypes Related to Schizophrenia. Cell Reports. PMID 27524619 DOI: 10.1016/J.Celrep.2016.07.044  0.788
2016 Tanda G, Mereu M, Hiranita T, Quarterman J, Coggiano M, Katz JL. Lack of Specific Involvement of (+)-Naloxone and (+)-Naltrexone on the Reinforcing and Neurochemical Effects of Cocaine and Opioids. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27296151 DOI: 10.1038/Npp.2016.91  0.336
2016 Miliano C, Serpelloni G, Rimondo C, Mereu M, Marti M, De Luca MA. Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants. Frontiers in Neuroscience. 10: 153. PMID 27147945 DOI: 10.3389/Fnins.2016.00153  0.305
2016 Marsilio I, Caputi V, Contarini G, Mereu M, Debetto P, Galuppini F, Lante I, Filpa V, Orso G, Rugge M, Crema F, Giaroni C, Papaleo F, Giron MC. 522 Catechol-O-Methyltransferase Genetic Reduction Evokes Small-Bowel Neuromuscular Adaptive Changes Gastroenterology. 150: S108. DOI: 10.1016/S0016-5085(16)30468-1  0.582
2015 Mereu M, Tronci V, Chun LE, Thomas AM, Green JL, Katz JL, Tanda G. Cocaine-induced endocannabinoid release modulates behavioral and neurochemical sensitization in mice. Addiction Biology. 20: 91-103. PMID 23910902 DOI: 10.1111/Adb.12080  0.367
2015 Caputi V, Marsilio I, Cavallo L, Frizzo SA, Marinelli F, Mereu M, Lante I, Orso G, Papaleo F, Giron MC. Mo2031 Involvement of Catechol-O-Methyltransferase Genetic Reduction in Murine Intestinal Dysmotility: A Possible Link Between Psychiatric Disorders and Irritable Bowel Syndrome Gastroenterology. 148: S-774-S-775. DOI: 10.1016/S0016-5085(15)32640-8  0.592
2014 Kohut SJ, Hiranita T, Hong SK, Ebbs AL, Tronci V, Green J, Garcés-Ramírez L, Chun LE, Mereu M, Newman AH, Katz JL, Tanda G. Preference for distinct functional conformations of the dopamine transporter alters the relationship between subjective effects of cocaine and stimulation of mesolimbic dopamine. Biological Psychiatry. 76: 802-9. PMID 24853388 DOI: 10.1016/J.Biopsych.2014.03.031  0.386
2013 Mereu M, Bonci A, Newman AH, Tanda G. The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders. Psychopharmacology. 229: 415-34. PMID 23934211 DOI: 10.1007/S00213-013-3232-4  0.301
2013 Tanda G, Li SM, Mereu M, Thomas AM, Ebbs AL, Chun LE, Tronci V, Green JL, Zou MF, Kopajtic TA, Newman AH, Katz JL. Relations between stimulation of mesolimbic dopamine and place conditioning in rats produced by cocaine or drugs that are tolerant to dopamine transporter conformational change. Psychopharmacology. 229: 307-21. PMID 23612854 DOI: 10.1007/S00213-013-3109-6  0.365
2013 Hiranita T, Mereu M, Soto PL, Tanda G, Katz JL. Self-administration of cocaine induces dopamine-independent self-administration of sigma agonists. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 605-15. PMID 23187725 DOI: 10.1038/Npp.2012.224  0.34
2013 Enrico P, Sirca D, Mereu M, Peana AT, Mercante B, Diana M. Acute restraint stress prevents nicotine-induced mesolimbic dopaminergic activation via a corticosterone-mediated mechanism: a microdialysis study in the rat. Drug and Alcohol Dependence. 127: 8-14. PMID 22809896 DOI: 10.1016/J.Drugalcdep.2012.06.006  0.759
2012 Loland CJ, Mereu M, Okunola OM, Cao J, Prisinzano TE, Mazier S, Kopajtic T, Shi L, Katz JL, Tanda G, Newman AH. R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse. Biological Psychiatry. 72: 405-13. PMID 22537794 DOI: 10.1016/J.Biopsych.2012.03.022  0.343
2011 Sirca D, Enrico P, Mereu M, Peana AT, Diana M. L-cysteine prevents ethanol-induced stimulation of mesolimbic dopamine transmission. Alcoholism, Clinical and Experimental Research. 35: 862-9. PMID 21303385 DOI: 10.1111/J.1530-0277.2010.01416.X  0.766
2011 Garcés-Ramírez L, Green JL, Hiranita T, Kopajtic TA, Mereu M, Thomas AM, Mesangeau C, Narayanan S, McCurdy CR, Katz JL, Tanda G. Sigma receptor agonists: receptor binding and effects on mesolimbic dopamine neurotransmission assessed by microdialysis. Biological Psychiatry. 69: 208-17. PMID 20950794 DOI: 10.1016/J.Biopsych.2010.07.026  0.367
2010 Peana AT, Muggironi G, Calvisi G, Enrico P, Mereu M, Nieddu M, Boatto G, Diana M. l-Cysteine reduces oral ethanol self-administration and reinstatement of ethanol-drinking behavior in rats. Pharmacology, Biochemistry, and Behavior. 94: 431-7. PMID 19879891 DOI: 10.1016/J.Pbb.2009.10.005  0.486
2009 Enrico P, Sirca D, Mereu M, Peana AT, Lintas A, Golosio A, Diana M. Acetaldehyde sequestering prevents ethanol-induced stimulation of mesolimbic dopamine transmission. Drug and Alcohol Dependence. 100: 265-71. PMID 19070441 DOI: 10.1016/J.Drugalcdep.2008.10.010  0.741
2007 Enrico P, Sirca D, Mereu M. Antioxidants, minerals, vitamins, and herbal remedies in tinnitus therapy. Progress in Brain Research. 166: 323-30. PMID 17956795 DOI: 10.1016/S0079-6123(07)66029-4  0.726
Show low-probability matches.